Peer Review History
| Original SubmissionJuly 19, 2019 |
|---|
|
PONE-D-19-20354 Cardio-metabolic abnormalities among patients with severe mental illness at a Regional Referral Hospital in southwestern Uganda PLOS ONE Dear Dr. Agaba, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. This manuscript describes the prevalence of abnormalities in cardio-metabolic risk factors among persons with a severe mental illness in southwestern Uganda. The manuscript shows a high level of abnormalities in SMI patients, which is alarming. I believe that the authors conducted a study that is very important for the organization of the mental health care situation in Uganda and that their data emphasizes the need for routine screening for cardio-metabolic abnormalities. I believe that the authors can significantly improve the paper by placing the outcomes as described in the paper in a wider context. Major revisions 1. The authors state that the aim of this study is to describe the cardio-metabolic abnormalities among patients with SMI attending the specific clinic at MRRH. However, after reading the introduction, it is unclear why the authors want to know these percentages; what do they want to do with these numbers? It is also unclear what the reference category is to which these numbers will be compared. Do the authors want to know the percentage of abnormalities in SMI patients as compared to the general population in Uganda, or as compared to SMI population in other countries? And why do the authors want to know this? The context of this study could be much more understandable if the authors explicitly state the underlying aim of why they want to know these percentages. 2. For the reader, the procedure of including patients in the study is unclear. The manuscript does not provide any information about the procedure to inform patients about the study and to sign informed consent (should be described in the method section, and not as one line in the ethics section). It is also unclear how many patients were eligible (i.e. how many patients were invited to participate), and how many patients refused to sign informed consent (drop-out; should be described in the Results section). In addition, in the discussion, the authors mention the sample size calculation (line 236), which is not even described in the method section. This is all very important information that is now lacking in the manuscript. 3. In the method section (line 86), the authors mention that they recruited a total of 304 patients. This is a result and should therefore be in the results section. 4. The authors state that the fasting blood sugar levels were obtained after eight hours of fasting. Is it realistic that patients had been fasting for eight hours? Or could the percentage of persons with pre-diabetes or diabetes be influenced by non-fasting blood sugar levels? 5. In the results section, the authors give number for ‘smokers’, ‘for ever taken alcohol’, and for ‘physical activity’. It is unclear what questions were used to get these data; I believe this should be mentioned in the method section. 6. Table 2: did the authors only include persons with the diagnosis ‘Schizophrenia’, or were other psychotic diagnoses related to schizophrenia also included? 7. Table 2: the variables mentioned in the table are not clear. ‘Antipsychotic’ is not bold, and as a reader I do not have a clue what the authors mean with this. Please clarify. Also, in Table 2, the use of the heading ‘Duration of psychotropic medication (yes)’, suggests that everyone uses psychotropic medication. After calculating the total numbers, is seems indeed that everyone is using medication. But, why are ‘antipsychotics’ framed as a separate variable and why are the types of medication for depression or bipolar disorder nog given? The order of the table and the missing information leaves the reader with questions, please adjust the table. 8. Discussion: because for the reader, it is unclear why the authors would like to study these percentages (what the bigger aim is of knowing these numbers?), the discussion reads like a story summing up percentages without truly delivering a message. The percentages from the study are compared to percentages in either other SMI populations and to percentages in the general population of Uganda. I think the authors could truly improve the discussion by making clear what they want to do with these numbers, and to whom they want to compare these numbers, so that they can come up with a more in-depth discussion what could be done with these numbers. Now, the discussion only represents four paragraphs in which the numbers are compared to others, without drawing a conclusion. I think only two paragraphs should be spend on comparing these numbers, and thereafter, the authors should focus on the wider picture. Also, the phrase ‘unhealthy lifestyles’ pops up now and then, it is slightly touched, but I think the authors have more ideas about the role of unhealthy lifestyles and the early detection of cardio-metabolic abnormalities in solving the problem of these high cardio-metabolic abnormalities. 9. The conclusion summaries actually all that the reader wants to know more of in the introduction and the discussion. I think the conclusion has a very clear message of the why the authors want to know these numbers and what they aim to do after knowing these numbers. I think that the message of the conclusion should be highlighted more in the introduction (why do you want to know this) and in the discussion (now you know this, what can you do with1 his information). Minor revisions 1. Please be consistent in the use of the word cardio-metabolic (cardio-metabolic vs cardiometabolic). 2. The sentence in the abstract from line 16 to 20 is unreadable, please rephrase. 3. The author describes in line 46 to 50 the known percentages of cardio-metabolic abnormalities in SMI patients found in two previous meta-analyses. For the reader it’s unclear why the percentage of smokers is included in this summary, since this is a lifestyle behavior, not a cardio-metabolic abnormality. 4. The Introduction reads as one large paragraph. I believe that the use of more paragraphs would provide a better structure of the paper. The author could for example start a new paragraph from line 54. Also, the method section could use some paragraphs. 5. In line 59, for the reader it’s unclear to what the word ‘they’ refers; it mostly reads as it refers to ‘lifestyle modification approaches’, but this is probably not what is meant. Please clarify in the text. 6. It is unclear what is meant with ‘acute symptoms with no insight’ (line 80). Please rephrase. 7. The words ‘history of smoking’ are mentioned twice in the summary (line 90 and 91). 8. When starting a new paragraph, it’s not preferable to start the first sentence with ‘These’ since the reader is unaware to what the word ‘these’ refers (line 112). 9. Line 117: please do not use a capital for the word Triglycerides 10. Please delete the word ‘obese’ in line 128, as it is redundant. 11. In my opinion, the sentence about data collection (line 145) should be in de method section, not in the ethics section. 12. In the tables, I believe it’s preferable to make the significant p-values bold, so it’s easier to scan the table. 13. In the tables, I would prefer to see the mean ± standarddeviation not including ( ). 14. In Table 1, the Overall numbers for Single persons do miss a ) . I think the 0 should be deleted and replaced by a ), also to keep the number of decimals equal in the table. In Table 1, also, a space between ‘Female(N=169)’ is needed. 15. The marital status ‘died’ is a bit odd; I think ‘widow(er)’ would be more appropriate. 16. Please replace the ‘&’ with ‘and’ throughout the whole manuscript 17. Please write numbers below ten as a word instead of a number, e.g., ‘3 psychiatrists’ should be ‘three psychiatrists’ 18. Please be consistent in the use of a space between the number and the percentage-sign throughout the whole manuscript (e.g. either 10% or 10 %). 19. Describe square meters using the superscript function (i.e. m2) 20. Line 192: it’s unclear where the word ‘that’ refers to, please clarify. We would appreciate receiving your revised manuscript by Dec 07 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Ying-Mei Feng Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf |
| Revision 1 |
|
Cardio-metabolic abnormalities among patients with severe mental illness at a Regional Referral Hospital in southwestern Uganda PONE-D-19-20354R1 Dear Dr. Agaba, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ying-Mei Feng Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-19-20354R1 Cardio-metabolic abnormalities among patients with severe mental illness at a Regional Referral Hospital in southwestern Uganda Dear Dr. Agaba: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr Ying-Mei Feng Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .